Currently, raw materials are being imported to make the drug widely used as pain reliever, fever reducer
Published Date – 5 January 2025, 05:31 PM
New Delhi: The government on Sunday announced indigenously-developed paracetamol drug by the Council of Scientific and Industrial Research (CSIR), which would reduce dependence on imported ingredients.
This innovation aims to make India self-reliant in paracetamol manufacturing aligning with Prime Minister Narendra Modi’s ‘Atmanirbhar Bharat’ vision, said Union Minister Dr Jitendra Singh.
The Minister elaborated that CSIR has developed indigenous technology to produce paracetamol, a widely used pain reliever and fever reducer. Currently, India imports the key raw materials for paracetamol from various countries. Karnataka-based Satya Deeptha Pharmaceuticals Ltd will utilise this breakthrough to produce affordable paracetamol domestically. “There have been a series of indigenous developments namely India’s first indigenously-developed antibiotic Nafithromycin to treat both atypical and typical drug-resistant bacteria,” said Dr Singh.
The Minister also congratulated the team of the Department of Scientific and Industrial Research (DSIR) on their 40th Foundation Day. The DSIR Foundation Day marked 16 more technology transfers: 9 CSIR-CSIO Chennai and 6 from CSIR-CEERI, Pilani. The technologies transferred by CSIO are in the area of design and development of scientific and industrial instruments with IoT enabled technologies, while transfers by CEERI are in the area of healthcare and societal implications.